PMH41 RISPERIDONE LONG ACTING INJECTION (RLAI) IN THE TREATMENT OF EARLY VERSUS LATE DIAGNOSIS PATIENTS WITH SCHIZOPHRENIA- INTERIM RESULTS FROM OBSERVATIONAL STUDIES CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM
May 1, 2007, 00:00
10.1016/S1098-3015(10)68792-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)68792-X/fulltext
Title :
PMH41 RISPERIDONE LONG ACTING INJECTION (RLAI) IN THE TREATMENT OF EARLY VERSUS LATE DIAGNOSIS PATIENTS WITH SCHIZOPHRENIA- INTERIM RESULTS FROM OBSERVATIONAL STUDIES CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68792-X&doi=10.1016/S1098-3015(10)68792-X
First page :
Section Title :
Open access? :
No
Section Order :
580